NASDAQ · VVORX
Invesco Value Opportunities R
$26.88-$0.25 (-0.92%)
Invesco Value Opportunities R’s quoted price sits in the upper half of its reported 52-week range, 5.82% below the high.
Loading market information…
NASDAQ · JPPEX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
JPMorgan Mid Cap Equity R6’s quoted price sits in the upper half of its reported 52-week range, 4.74% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JPMorgan Mid Cap Equity R6’s forward annual dividend is $3.62 per share, paid annual. The forward yield is 5.18% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Under normal circumstances, the fund invests at least 80% of its assets in equity securities of mid cap companies. "Assets" means net assets, plus the amount of borrowings for investment purposes. Mid cap companies are companies with market capitalizations equal to those within the universe of the Russell Midcap® Index at the time of purchase.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$26.88-$0.25 (-0.92%)
Invesco Value Opportunities R’s quoted price sits in the upper half of its reported 52-week range, 5.82% below the high.
$41.90-$1.21 (-2.81%)
DFA Emerging Markets Portfolio I’s quoted price sits in the lower half of its reported 52-week range, 14.24% below the high.
$75.63-$1.06 (-1.38%)
Permanent Portfolio Permanent I’s quoted price sits in the lower half of its reported 52-week range, 9.63% below the high.
$30.91-$0.52 (-1.65%)
Fidelity Select Health Care Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$30.48-$0.40 (-1.3%)
U.S. High Relative Profitability Portfolio Institutional Class’s quoted price sits in the upper half of its reported 52-week range, 1.3% below the high.
$69.38+$0.29 (+0.42%)
BlackRock Health Sciences Opportunities Portfolio Service Shares’s quoted price sits in the upper half of its reported 52-week range, 1.22% below the high.
$68.92+$0.28 (+0.41%)
BlackRock Health Sciences Opportunities Portfolio Investor A Shares’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$62.37-$1.23 (-1.93%)
Calvert U.S. Large Cap Core Responsible Index Fund - Class R6’s quoted price sits in the upper half of its reported 52-week range, 4.38% below the high.
